CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total Revenue	$ 0	$ 4,310
Operating expenses:
Research and development	4,760	6,078
General and administrative	8,975	5,293
Change in fair value of contingent consideration	(12,900)	48,160
Total operating expenses	835	59,531
Loss from Operations	(835)	(55,221)
Other income (expense), net	28	(3)
Loss Before Taxes	(807)	(55,224)
Provision for income taxes	0	(288)
Net Loss After Taxes	(807)	(55,512)
Comprehensive Loss After Taxes	(807)	(55,512)
Net loss attributable to common stockholders - basic	(807)	(55,512)
Net loss attributable to common stockholders - diluted	$ (807)	$ (55,512)
Net loss per common share - basic (in dollars per share)	$ (0.00)	$ (0.35)
Net loss per common share - diluted (in dollars per share)	$ (0.00)	$ (0.35)
Weighted-average common shares outstanding - basic (in shares)	199,464	157,033
Weighted-average common shares outstanding - diluted (in shares)	199,464	157,033
License and related revenue
Total Revenue	$ 0	$ 4,310